Jiangsu Chinagreen Biological Technology Group Co Ltd

Jiangsu Chinagreen maintains a relatively strong liquidity position, with a current ratio of 3.4, indicating the company can cover its short-term liabilities more than three times over. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. The debt-to-equity ratio of 0.35 suggests a conservative capital structure, with equity financing playing a dominant role in the company's capital base.

Profitability metrics show a return on equity (ROE) of 6.74% and a return on assets (ROA) of 4.47%, both below the median for the Fishing & Farming industry. This indicates that the company is generating returns, but at a slower pace than its industry peers. The operating margin, calculated as operating income of 123.3 million CNY on revenue of 1.29 billion CNY, is 9.55%, which is in line with the industry's average operating margin of 10.0%.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes. The company's operations are entirely within China, and it does not report revenue by geographic region, making it difficult to assess exposure to regional risks.

Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction projected in the next fiscal year. The capital expenditure of -123.1 million CNY indicates a reduction in investment, which may signal a shift toward cost optimization or a slowdown in expansion. The company's free cash flow of 184.6 million CNY supports its ability to fund operations and potentially return value to shareholders.

The company faces moderate liquidity risk due to its negative net cash position after debt, and the risk of dilution is currently low. No recent equity issuance or dilutive events have been reported, and the number of shares outstanding has remained unchanged. The company has not disclosed any material regulatory or geopolitical risks in its recent filings, but as a Chinese-based firm, it may be indirectly affected by broader trade tensions or policy shifts.

No recent events, such as earnings calls, regulatory filings, or press releases, have been disclosed in the available data. The company's financial statements do not include any material changes in strategy or operations in the most recent reporting period.